Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Nanoparticles
100%
Liposomal
100%
Uterine Leiomyoma
100%
2-mercaptoethanol (2-ME)
100%
Mouse Xenograft Model
100%
Pharmacokinetics
22%
Tumor Tissue
22%
Cleaved caspase-3
22%
Leiomyoma
22%
Proliferation Marker Ki-67
22%
Treatment Options
11%
Therapeutic Strategies
11%
Immunohistochemistry
11%
Mouse Model
11%
Clinical Trials
11%
Estrogen
11%
Antitumor Agents
11%
Patient-derived Xenograft
11%
Ultrasound
11%
Immunodeficient
11%
Medical Treatment
11%
Progesterone
11%
Cell Activity
11%
Maximum Tolerated Dose
11%
Intraperitoneal Injection
11%
Tumor Volume
11%
Caspase-3 Expression
11%
Apoptosis Markers
11%
Leiomyoma Cells
11%
Cell Proliferation Markers
11%
In Vivo Delivery
11%
Challenging Problems
11%
Caliper
11%
Liposomal Nanoparticles
11%
Nanoparticle Formulation
11%
Model Priors
11%
NOG Mice
11%
Promising Therapeutics
11%
Tumor Growth Inhibition
11%
Patient-derived
11%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Nanoparticle
100%
Uterus Myoma
100%
2-Methoxyestradiol
100%
Neoplasm
44%
Leiomyoma
33%
Caspase 3
22%
Pharmacokinetics
22%
Clinical Trial
11%
Progesterone
11%
Intraperitoneal Injection
11%
Cancer Inhibition
11%
Maximum Tolerated Dose
11%
Estrogen
11%